Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400696 · ClinicalTrials.gov registry record · NA
Web-based Weight Loss Intervention
A NA study, sponsored by 23andMe.
- Completed
- Registry status
- NA
- Development phase
- 63,656
- Enrollment target
NCT03400696 is a NA study that has completed, run by 23andMe. The registered enrollment target is 63,656 participants.
The verdict
NCT03400696, a NA study, has completed, sponsored by 23andMe.
- COMPLETED
- Registry status
- NA
- Development phase
- 63,656 participants
- Enrollment target
Study Summary
Excess weight is a major risk factor underlying leading causes of death globally, including cardiovascular disease, type 2 diabetes, and some cancers. Among participants assigned to the same lifestyle intervention arms in prior weight loss randomized controlled trials, large inter-individual differences in weight loss success have been observed, ranging from \>50lbs of weight loss to \>10lbs of weight gain. Both genetic and non-genetic factors underlying differential adherence and weight loss success are poorly understood.
Interventions
- BEHAVIORAL Lower carbohydrate diet
- BEHAVIORAL Higher fiber diet
- BEHAVIORAL Physical activity focused
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63,656 participants |
| Start Date | 2017-12-27 |
| Est. Completion | 2019-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400696
The ClinicalTrials.gov registry entry for NCT03400696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63,656 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 23andMe, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lower carbohydrate diet is the first listed.
NCT03400696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03400696 about?
NCT03400696 is a clinical study titled "Web-based Weight Loss Intervention". Excess weight is a major risk factor underlying leading causes of death globally, including cardiovascular disease, type 2 diabetes, and some cancers. Among participants assigned to the same lifestyle intervention arms in prior weight loss randomized controlled trials, large inter-individual differe...
What is the current status of trial NCT03400696?
This trial is currently completed. It is a NA study. The enrollment target is 63,656 participants. The study started on 2017-12-27. Estimated completion is 2019-04-16.
What interventions are being tested in trial NCT03400696?
The interventions under investigation include: Lower carbohydrate diet (BEHAVIORAL), Higher fiber diet (BEHAVIORAL), Physical activity focused (BEHAVIORAL).
Who is sponsoring clinical trial NCT03400696?
This trial is sponsored by 23andMe, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.